(IMAGE)

Kumamoto University

Caption

The new peptide vaccine from researchers at Kumamoto University targets ANGPTL3 and improves dyslipidemia, fatty liver, and atherosclerosis in mice.

Credit

Kumamoto University

Usage Restrictions

No restrictions.

License

Public Domain

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.